Advertisement
Advertisement
U.S. Markets open in 6 hrs 39 mins
Advertisement
Advertisement
Advertisement
Advertisement

Yield10 Bioscience, Inc. (YTEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.9300-0.3300 (-6.27%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.2600
Open5.2200
Bid4.9400 x 1100
Ask5.1700 x 2200
Day's Range4.8200 - 5.2200
52 Week Range4.6100 - 23.4900
Volume123,317
Avg. Volume157,640
Market Cap24.002M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-3.0320
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.33
  • Simply Wall St.

    Will Yield10 Bioscience (NASDAQ:YTEN) Spend Its Cash Wisely?

    We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

  • Zacks

    Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates

    Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of 22.22% and -57.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Yield10 Bioscience Announces Third Quarter 2021 Financial Results

    Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate UpdateWOBURN, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial and operational results for the three and nine months ended September 30, 2021. “During the third quarter we continued to execute against our strategic objectives for 2021," said Oliver Peoples, Ph.D., Chief Executive Officer of

Advertisement
Advertisement